TOK-8801

• Description:

  TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.

• UNSPSC:

  12352005

• Target:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/TOK-8801.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=C(C)N2C(S1)=NC(C)(C)C2)NCCC3=CC=CC=C3

• Molecular Formula:

  C17H21N3OS

• Molecular Weight:

  315.43

• References & Citations:

  [1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide) . Jpn J Pharmacol. 1989 Dec;51 (4) :549-54.|[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12 (5) :497-502.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [105963-46-0]